Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Medpace Holdings, Inc. (MEDP) vs Twist Bioscience Corporation (TWST)

Medpace Holdings, Inc. and Twist Bioscience Corporation are both Diagnostics & Research companies. Medpace Holdings, Inc. is the larger, with a market value of $17.3B against $12.4B — 1.4× the size. Twist Bioscience Corporation has negative trailing earnings, so its P/E is not meaningful; Medpace Holdings, Inc. trades at 35.6×. Medpace Holdings, Inc. grew revenue faster over the last twelve months: 24.7% against 19.2%. Medpace Holdings, Inc. has the higher net margin (17.7% vs −31.7%) and the higher return on invested capital (0.00% vs −30.8%). Across the 19 metrics below, Medpace Holdings, Inc. leads on 15 and Twist Bioscience Corporation on 4.

Valuation

Metric MEDP TWST Diagnostics & Research median
P/E 35.59 n/m 33.95
P/S 6.27 26.49 4.87
P/B 40.19 25.66 3.12
Price to free cash flow 24.67 n/m 34.02
EV/EBITDA 27.97 n/m 25.20
EV/Sales 6.14 26.18 5.66
Earnings yield 2.81% (1.21%) (1.75%)
Free cash flow yield 4.05% (0.84%) (0.13%)

Profitability

Metric MEDP TWST Diagnostics & Research median
Gross margin 72.35% 51.97% 50.89%
Operating margin 20.97% (33.58%) (8.57%)
Net margin 17.67% (31.66%) (6.37%)
Free cash flow margin 25.40% (22.15%) 0.00%
Return on equity 162.15% (29.59%) (2.92%)
Return on assets 27.09% (20.78%) (6.71%)
Return on invested capital 0.00% (30.83%) 0.00%

Growth

Metric MEDP TWST Diagnostics & Research median
Revenue growth (TTM) 24.67% 19.19% 7.69%
EPS growth (last fiscal year) 20.98% 63.89% —
Revenue growth, 5-year CAGR 22.27% 33.11% 7.40%
Net income growth, 5-year CAGR 25.50% 0.00% 0.00%

Health

Metric MEDP TWST Diagnostics & Research median
Debt to equity 0.00 0.03 0.11
Current ratio 0.73 2.67 2.02
Net debt to EBITDA (0.88) 1.95 0.78

Dividend

Metric MEDP TWST Diagnostics & Research median
Dividend yield — — 0.70%
Payout ratio 0.00 0.00 0.00

Size

Metric MEDP TWST Diagnostics & Research median
Market cap 17.32b 12.39b 2.56b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack